September 22, 2007
Pfizer, Organon end asenapine deal
Pfizer and Organon said Tuesday they discontinued their collaboration on asenapine, a potential treatment for schizophrenia and bipolar disorder. Organon …
More: continued here
Pfizer and Organon said Tuesday they discontinued their collaboration on asenapine, a potential treatment for schizophrenia and bipolar disorder. Organon …
More: continued here
Filed under Bipolar Disorder Treatment by mailer